日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients

基于血清的VeriStrat®检测与非小细胞肺癌患者的促炎反应物和临床结果相关

Fidler, Mary Jo; Fhied, Cristina L; Roder, Joanna; Basu, Sanjib; Sayidine, Selina; Fughhi, Ibtihaj; Pool, Mark; Batus, Marta; Bonomi, Philip; Borgia, Jeffrey A

Differential expression of circulating biomarkers of tumor phenotype and outcomes in previously treated non-small cell lung cancer patients receiving erlotinib vs. cytotoxic chemotherapy

既往接受过治疗的非小细胞肺癌患者,接受厄洛替尼治疗与接受细胞毒性化疗后,循环肿瘤表型和预后生物标志物的表达存在差异

Fidler, Mary Jo; Frankenberger, Casey; Seto, Richard; Lobato, Gabriela C; Fhied, Cristina L; Sayidine, Selina; Basu, Sanjib; Pool, Mark; Karmali, Reem; Batus, Marta; Lie, Wen-Rong; Hayes, David; Mistry, Jehangir; Bonomi, Philip; Borgia, Jeffrey A